Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05920850 · ClinicalTrials.gov registry record · NA
The SHARED, Project, Lung Cancer Screening for African American Men (AAM)
A NA study of Lung Cancer Screening, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
- 1
- Study location
NCT05920850: Completed NA study of Lung Cancer Screening, sponsored by University of Illinois at Chicago.
NCT05920850 is a NA study of Lung Cancer Screening that has completed, run by University of Illinois at Chicago. The registered enrollment target is 37 participants, below the 524-participant average among 7 other Lung Cancer Screening trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05920850, a NA study of Lung Cancer Screening, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a single-arm pre-test post-test design with a two-month follow-up assessment. The study aims to provide support to participants in quitting smoking and accessing lung cancer screening through the combination of education interventions and patient navigation (PN)
Primary Outcome
Number of participants that show an improvement from pretest to posttest
Conditions Studied
Interventions
- OTHER Educational Video about LDCT lung cancer screening
- OTHER A culturally tailored shared decision-making tool
- OTHER Flip chart
- OTHER Navigation support
Study Locations (1)
Illinois
- University of Illinois - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2023-07-14 |
| Est. Completion | 2024-01-31 |
| Phase | NA |
What the finished NCT05920850 record still lists
NCT05920850 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 37 participants, a relatively small participant target, below the 524-participant average among 7 other Lung Cancer Screening trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Lung Cancer Screening appearing as the primary indexed condition, and to 4 interventions - of which Educational Video about LDCT lung cancer screening is the first listed.
NCT05920850 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05920850 about?
NCT05920850 is a clinical study titled "The SHARED, Project, Lung Cancer Screening for African American Men (AAM)". This study is a single-arm pre-test post-test design with a two-month follow-up assessment. The study aims to provide support to participants in quitting smoking and accessing lung cancer screening through the combination of education interventions and patient navigation (PN)
What is the current status of trial NCT05920850?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2023-07-14. Estimated completion is 2024-01-31.
What conditions does trial NCT05920850 study?
This clinical trial studies the following conditions: Lung Cancer Screening.
What interventions are being tested in trial NCT05920850?
The interventions under investigation include: Educational Video about LDCT lung cancer screening (OTHER), A culturally tailored shared decision-making tool (OTHER), Flip chart (OTHER), Navigation support (OTHER).
Who is sponsoring clinical trial NCT05920850?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05920850 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer Screening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Advancing Lung Cancer Screening One Text at a Time
RECRUITING · NA
-
Digitally Enhanced Smoking Cessation for High Risk Smokers
ACTIVE NOT RECRUITING · NA
-
Multilevel Interventions to Increase Adherence to Lung Cancer Screening
ACTIVE NOT RECRUITING · NA
-
Incorporating Veterans' Preferences Into Lung Cancer Screening Decisions
COMPLETED · NA
-
A Study of Lung Cancer Screening in People With Unexplained Weight Loss
RECRUITING
-
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI